{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:50:05Z","timestamp":1791175805727,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T00:00:00Z","timestamp":1454889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/nrneph.2016.7","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T05:56:19Z","timestamp":1454910979000},"page":"241-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Mesenchymal stromal cells in renal transplantation: opportunities and challenges"],"prefix":"10.1038","volume":"12","author":[{"given":"Federica","family":"Casiraghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Perico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cortinovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"BFnrneph20167_CR1","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.2004121113","volume":"16","author":"CN Kotton","year":"2005","unstructured":"Kotton, C. N. & Fishman, J. A. Viral infection in the renal transplant recipient. J. Am. Soc. Nephrol. 16, 1758\u20131774 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20167_CR2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrneph.2010.102","volume":"6","author":"I Rama","year":"2010","unstructured":"Rama, I. & Grinyo, J. M. Malignancy after renal transplantation: the role of immunosuppression. Nat. Rev. Nephrol. 6, 511\u2013519 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph20167_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","volume":"28","author":"S Stoumpos","year":"2015","unstructured":"Stoumpos, S., Jardine, A. G. & Mark, P. B. Cardiovascular morbidity and mortality after kidney transplantation. Transpl. Int. 28, 10\u201321 (2015).","journal-title":"Transpl. Int."},{"key":"BFnrneph20167_CR4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/dme.12534","volume":"31","author":"N Tufton","year":"2014","unstructured":"Tufton, N.  et al. New-onset diabetes after renal transplantation. Diabet. Med. 31, 1284\u20131292 (2014).","journal-title":"Diabet. Med."},{"key":"BFnrneph20167_CR5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MNH.0b013e32834b4343","volume":"20","author":"MJ Casey","year":"2011","unstructured":"Casey, M. J. & Meier-Kriesche, H. U. Calcineurin inhibitors in kidney transplantation: friend or foe? Curr. Opin. Nephrol. Hypertens. 20, 610\u2013615 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph20167_CR6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","volume":"11","author":"SA Lodhi","year":"2011","unstructured":"Lodhi, S. A., Lamb, K. E. & Meier-Kriesche, H. U. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am. J. Transplant. 11, 1226\u20131235 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1172\/JCI200114142","volume":"108","author":"AD Salama","year":"2001","unstructured":"Salama, A. D., Remuzzi, G., Harmon, W. E. & Sayegh, M. H. Challenges to achieving clinical transplantation tolerance. J. Clin. Invest. 108, 943\u2013948 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph20167_CR8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/ajt.12731","volume":"14","author":"T Kawai","year":"2014","unstructured":"Kawai, T.  et al. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am. J. Transplant. 14, 1599\u20131611 (2014).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR9","doi-asserted-by":"crossref","first-page":"124ra28","DOI":"10.1126\/scitranslmed.3003509","volume":"4","author":"J Leventhal","year":"2012","unstructured":"Leventhal, J.  et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci. Transl. Med. 4, 124ra28 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFnrneph20167_CR10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa074191","volume":"358","author":"JD Scandling","year":"2008","unstructured":"Scandling, J. D.  et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N. Engl. J. Med. 358, 362\u2013368 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph20167_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3227","volume":"12","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J., Bushell, A. & Hester, J. Regulatory immune cells in transplantation. Nat. Rev. Immunol. 12, 417\u2013430 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrneph20167_CR12","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein, A. J., Chailakhjan, R. K. & Lalykina, K. S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3, 393\u2013403 (1970).","journal-title":"Cell Tissue Kinet."},{"key":"BFnrneph20167_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F. & Keiliss-Borok, I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331\u2013340 (1974).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR14","first-page":"42","volume":"136","author":"M Owen","year":"1988","unstructured":"Owen, M. & Friedenstein, A. J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42\u201360 (1988).","journal-title":"Ciba Found. Symp."},{"key":"BFnrneph20167_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","volume":"19","author":"P Bianco","year":"2013","unstructured":"Bianco, P.  et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35\u201342 (2013).","journal-title":"Nat. Med."},{"key":"BFnrneph20167_CR16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","volume":"131","author":"B Sacchetti","year":"2007","unstructured":"Sacchetti, B.  et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324\u2013336 (2007).","journal-title":"Cell"},{"key":"BFnrneph20167_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S Mendez-Ferrer","year":"2010","unstructured":"Mendez-Ferrer, S.  et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829\u2013834 (2010).","journal-title":"Nature"},{"key":"BFnrneph20167_CR18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","volume":"2","author":"P Bianco","year":"2008","unstructured":"Bianco, P., Robey, P. G. & Simmons, P. J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313\u2013319 (2008).","journal-title":"Cell Stem Cell"},{"key":"BFnrneph20167_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M.  et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"key":"BFnrneph20167_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan, M.  et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301\u2013313 (2008).","journal-title":"Cell Stem Cell"},{"key":"BFnrneph20167_CR21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/nm.2539","volume":"17","author":"VL Bautch","year":"2011","unstructured":"Bautch, V. L. Stem cells and the vasculature. Nat. Med. 17, 1437\u20131443 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph20167_CR22","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L da Silva Meirelles","year":"2006","unstructured":"da Silva Meirelles, L., Chagastelles, P. C. & Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119, 2204\u20132213 (2006).","journal-title":"J. Cell Sci."},{"key":"BFnrneph20167_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-5699(90)90033-6","volume":"11","author":"RI Lechler","year":"1990","unstructured":"Lechler, R. I., Lombardi, G., Batchelor, J. R., Reinsmoen, N. & Bach, F. H. The molecular basis of alloreactivity. Immunol. Today 11, 83\u201388 (1990).","journal-title":"Immunol. Today"},{"key":"BFnrneph20167_CR24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.2014.430","volume":"87","author":"Q Zhuang","year":"2015","unstructured":"Zhuang, Q. & Lakkis, F. G. Dendritic cells and innate immunity in kidney transplantation. Kidney Int. 87, 712\u2013718 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph20167_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0008-8749(77)90269-6","volume":"29","author":"P Matzinger","year":"1977","unstructured":"Matzinger, P. & Bevan, M. J. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell. Immunol. 29, 1\u20135 (1977).","journal-title":"Cell. Immunol."},{"key":"BFnrneph20167_CR26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","volume":"166","author":"EJ Suchin","year":"2001","unstructured":"Suchin, E. J.  et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166, 973\u2013981 (2001).","journal-title":"J. Immunol."},{"key":"BFnrneph20167_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","volume":"93","author":"KJ Wood","year":"2012","unstructured":"Wood, K. J. & Goto, R. Mechanisms of rejection: current perspectives. Transplantation 93, 1\u201310 (2012).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/imr.12038","volume":"252","author":"Z Liu","year":"2013","unstructured":"Liu, Z., Fan, H. & Jiang, S. CD4+ T-cell subsets in transplantation. Immunol. Rev. 252, 183\u2013191 (2013).","journal-title":"Immunol. Rev."},{"key":"BFnrneph20167_CR29","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1084\/jem.165.5.1296","volume":"165","author":"AS Rosenberg","year":"1987","unstructured":"Rosenberg, A. S., Mizuochi, T., Sharrow, S. O. & Singer, A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165, 1296\u20131315 (1987).","journal-title":"J. Exp. Med."},{"key":"BFnrneph20167_CR30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.coi.2004.07.011","volume":"16","author":"S Jiang","year":"2004","unstructured":"Jiang, S., Herrera, O. & Lechler, R. I. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol. 16, 550\u2013557 (2004).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrneph20167_CR31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/01.tp.0000287457.54761.53","volume":"84","author":"CY Lee","year":"2007","unstructured":"Lee, C. Y.  et al. The involvement of FcR mechanisms in antibody-mediated rejection. Transplantation 84, 1324\u20131334 (2007).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","volume":"25","author":"MA Williams","year":"2007","unstructured":"Williams, M. A. & Bevan, M. J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171\u2013192 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrneph20167_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1600-065X.2003.00087.x","volume":"196","author":"A Valujskikh","year":"2003","unstructured":"Valujskikh, A. & Lakkis, F. G. In remembrance of things past: memory T cells and transplant rejection. Immunol. Rev. 196, 65\u201374 (2003).","journal-title":"Immunol. Rev."},{"key":"BFnrneph20167_CR34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2006101143","volume":"18","author":"M Noris","year":"2007","unstructured":"Noris, M.  et al. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J. Am. Soc. Nephrol. 18, 1007\u20131018 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20167_CR35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","volume":"5","author":"JP Pearl","year":"2005","unstructured":"Pearl, J. P.  et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 5, 465\u2013474 (2005).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.smim.2007.10.004","volume":"19","author":"KM Williams","year":"2007","unstructured":"Williams, K. M., Hakim, F. T. & Gress, R. E. T cell immune reconstitution following lymphodepletion. Semin. Immunol. 19, 318\u2013330 (2007).","journal-title":"Semin. Immunol."},{"key":"BFnrneph20167_CR37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MOT.0b013e328332bd4a","volume":"14","author":"AJ Page","year":"2009","unstructured":"Page, A. J., Ford, M. L. & Kirk, A. D. Memory T-cell-specific therapeutics in organ transplantation. Curr. Opin. Organ Transplant. 14, 643\u2013649 (2009).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"BFnrneph20167_CR38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky, A. Y. Regulatory T cells and Foxp3. Immunol. Rev. 241, 260\u2013268 (2011).","journal-title":"Immunol. Rev."},{"key":"BFnrneph20167_CR39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1172\/JCI67226","volume":"124","author":"H Waldmann","year":"2014","unstructured":"Waldmann, H., Hilbrands, R., Howie, D. & Cobbold, S. Harnessing FOXP3+ regulatory T cells for transplantation tolerance. J. Clin. Invest. 124, 1439\u20131445 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph20167_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","volume":"115","author":"K English","year":"2008","unstructured":"English, K., Barry, F. P. & Mahon, B. P. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol. Lett. 115, 50\u201358 (2008).","journal-title":"Immunol. Lett."},{"key":"BFnrneph20167_CR41","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1073\/pnas.1103650108","volume":"108","author":"S Chiesa","year":"2011","unstructured":"Chiesa, S.  et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc. Natl Acad. Sci. USA 108, 17384\u201317389 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph20167_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","volume":"13","author":"W Zhang","year":"2004","unstructured":"Zhang, W.  et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 13, 263\u2013271 (2004).","journal-title":"Stem Cells Dev."},{"key":"BFnrneph20167_CR43","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang, X. X.  et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105, 4120\u20134126 (2005).","journal-title":"Blood"},{"key":"BFnrneph20167_CR44","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","volume":"177","author":"AJ Nauta","year":"2006","unstructured":"Nauta, A. J., Kruisselbrink, A. B., Lurvink, E., Willemze, R. & Fibbe, W. E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 177, 2080\u20132087 (2006).","journal-title":"J. Immunol."},{"key":"BFnrneph20167_CR45","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1634\/stemcells.2006-0548","volume":"25","author":"F Djouad","year":"2007","unstructured":"Djouad, F.  et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25, 2025\u20132032 (2007).","journal-title":"Stem Cells"},{"key":"BFnrneph20167_CR46","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4049\/jimmunol.180.3.1598","volume":"180","author":"YP Li","year":"2008","unstructured":"Li, Y. P.  et al. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J. Immunol. 180, 1598\u20131608 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneph20167_CR47","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari, G. M., Abdelrazik, H., Becchetti, F. & Moretta, L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2 . Blood 113, 6576\u20136583 (2009).","journal-title":"Blood"},{"key":"BFnrneph20167_CR48","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","volume":"105","author":"S Beyth","year":"2005","unstructured":"Beyth, S.  et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214\u20132219 (2005).","journal-title":"Blood"},{"key":"BFnrneph20167_CR49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew, A.  et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42\u201348 (2002).","journal-title":"Exp. Hematol."},{"key":"BFnrneph20167_CR50","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","volume":"105","author":"S Glennie","year":"2005","unstructured":"Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W. & Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821\u20132827 (2005).","journal-title":"Blood"},{"key":"BFnrneph20167_CR51","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","volume":"101","author":"M Krampera","year":"2003","unstructured":"Krampera, M.  et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722\u20133729 (2003).","journal-title":"Blood"},{"key":"BFnrneph20167_CR52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"WT Tse","year":"2003","unstructured":"Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C. & Guinan, E. C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389\u2013397 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","volume":"112","author":"H Karlsson","year":"2008","unstructured":"Karlsson, H.  et al. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood 112, 532\u2013541 (2008).","journal-title":"Blood"},{"key":"BFnrneph20167_CR54","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.4049\/jimmunol.1202710","volume":"190","author":"JL Reading","year":"2013","unstructured":"Reading, J. L.  et al. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity. J. Immunol. 190, 4542\u20134552 (2013).","journal-title":"J. Immunol."},{"key":"BFnrneph20167_CR55","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I Rasmusson","year":"2003","unstructured":"Rasmusson, I., Ringden, O., Sundberg, B. & Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76, 1208\u20131213 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR56","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.leu.2403871","volume":"19","author":"J Plumas","year":"2005","unstructured":"Plumas, J.  et al. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19, 1597\u20131604 (2005).","journal-title":"Leukemia"},{"key":"BFnrneph20167_CR57","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel, R.  et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619\u20134621 (2004).","journal-title":"Blood"},{"key":"BFnrneph20167_CR58","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal, S. & Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815\u20131822 (2005).","journal-title":"Blood"},{"key":"BFnrneph20167_CR59","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola, M.  et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838\u20133843 (2002).","journal-title":"Blood"},{"key":"BFnrneph20167_CR60","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","volume":"116","author":"F Gieseke","year":"2010","unstructured":"Gieseke, F.  et al. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116, 3770\u20133779 (2010).","journal-title":"Blood"},{"key":"BFnrneph20167_CR61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-3083.2010.02378.x","volume":"71","author":"M Sioud","year":"2010","unstructured":"Sioud, M., Mobergslien, A., Boudabous, A. & Floisand, Y. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation. Scand. J. Immunol. 71, 267\u2013274 (2010).","journal-title":"Scand. J. Immunol."},{"key":"BFnrneph20167_CR62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A Nasef","year":"2007","unstructured":"Nasef, A.  et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84, 231\u2013237 (2007).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K Sato","year":"2007","unstructured":"Sato, K.  et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109, 228\u2013234 (2007).","journal-title":"Blood"},{"key":"BFnrneph20167_CR64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren, G.  et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141\u2013150 (2008).","journal-title":"Cell Stem Cell"},{"key":"BFnrneph20167_CR65","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","volume":"27","author":"G Ren","year":"2009","unstructured":"Ren, G.  et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27, 1954\u20131962 (2009).","journal-title":"Stem Cells"},{"key":"BFnrneph20167_CR66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford, P.  et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res. Ther. 4, 65 (2013).","journal-title":"Stem Cell Res. Ther."},{"key":"BFnrneph20167_CR67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","volume":"156","author":"K English","year":"2009","unstructured":"English, K.  et al. Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25High forkhead box P3+ regulatory T cells. Clin. Exp. Immunol. 156, 149\u2013160 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph20167_CR68","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","volume":"26","author":"Z Selmani","year":"2008","unstructured":"Selmani, Z.  et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26, 212\u2013222 (2008).","journal-title":"Stem Cells"},{"key":"BFnrneph20167_CR69","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","volume":"31","author":"SM Melief","year":"2013","unstructured":"Melief, S. M.  et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 31, 1980\u20131991 (2013).","journal-title":"Stem Cells"},{"key":"BFnrneph20167_CR70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama, K.  et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell 10, 544\u2013555 (2012).","journal-title":"Cell Stem Cell"},{"key":"BFnrneph20167_CR71","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.12857","volume":"93","author":"S Tabera","year":"2008","unstructured":"Tabera, S.  et al. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93, 1301\u20131309 (2008).","journal-title":"Haematologica"},{"key":"BFnrneph20167_CR72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.2014.0155","volume":"24","author":"MM Rosado","year":"2015","unstructured":"Rosado, M. M.  et al. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. Stem Cells Dev. 24, 93\u2013103 (2015).","journal-title":"Stem Cells Dev."},{"key":"BFnrneph20167_CR73","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.exphem.2009.01.005","volume":"37","author":"S Asari","year":"2009","unstructured":"Asari, S.  et al. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 37, 604\u2013615 (2009).","journal-title":"Exp. Hematol."},{"key":"BFnrneph20167_CR74","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/stem.1881","volume":"33","author":"M Franquesa","year":"2015","unstructured":"Franquesa, M.  et al. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells 33, 880\u2013891 (2015).","journal-title":"Stem Cells"},{"key":"BFnrneph20167_CR75","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.transproceed.2006.10.002","volume":"38","author":"HP Zhou","year":"2006","unstructured":"Zhou, H. P.  et al. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant. Proc. 38, 3046\u20133051 (2006).","journal-title":"Transplant. Proc."},{"key":"BFnrneph20167_CR76","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","volume":"81","author":"S Inoue","year":"2006","unstructured":"Inoue, S.  et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81, 1589\u20131595 (2006).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR77","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood-2007-02-075481","volume":"110","author":"D Chabannes","year":"2007","unstructured":"Chabannes, D.  et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110, 3691\u20133694 (2007).","journal-title":"Blood"},{"key":"BFnrneph20167_CR78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2008.08.004","volume":"20","author":"FC Popp","year":"2008","unstructured":"Popp, F. C.  et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl. Immunol. 20, 55\u201360 (2008).","journal-title":"Transpl. Immunol."},{"key":"BFnrneph20167_CR79","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/stem.633","volume":"29","author":"VD Roobrouck","year":"2011","unstructured":"Roobrouck, V. D.  et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29, 871\u2013882 (2011).","journal-title":"Stem Cells"},{"key":"BFnrneph20167_CR80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/icb.2012.64","volume":"91","author":"SA Jacobs","year":"2013","unstructured":"Jacobs, S. A., Roobrouck, V. D., Verfaillie, C. M. & Van Gool, S. W. Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol. Cell Biol. 91, 32\u201339 (2013).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrneph20167_CR81","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5966\/sctm.2012-0166","volume":"2","author":"E Eggenhofer","year":"2013","unstructured":"Eggenhofer, E.  et al. Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression. Stem Cells Transl. Med. 2, 595\u2013606 (2013).","journal-title":"Stem Cells Transl. Med."},{"key":"BFnrneph20167_CR82","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1401776","volume":"193","author":"N Obermajer","year":"2014","unstructured":"Obermajer, N.  et al. Conversion of Th17 into IL-17Aneg regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy. J. Immunol. 193, 4988\u20134999 (2014).","journal-title":"J. Immunol."},{"key":"BFnrneph20167_CR83","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1600-6143.2009.02721.x","volume":"9","author":"W Ge","year":"2009","unstructured":"Ge, W.  et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am. J. Transplant. 9, 1760\u20131772 (2009).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR84","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","volume":"181","author":"F Casiraghi","year":"2008","unstructured":"Casiraghi, F.  et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J. Immunol. 181, 3933\u20133946 (2008).","journal-title":"J. Immunol."},{"key":"BFnrneph20167_CR85","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2009.01.003","volume":"32","author":"MG Solari","year":"2009","unstructured":"Solari, M. G.  et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J. Autoimmun. 32, 116\u2013124 (2009).","journal-title":"J. Autoimmun."},{"key":"BFnrneph20167_CR86","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2119\/molmed.2010.00098","volume":"17","author":"YH Kim","year":"2011","unstructured":"Kim, Y. H.  et al. Interleukin (IL)-10 induced by CD11b+ cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts. Mol. Med. 17, 697\u2013708 (2011).","journal-title":"Mol. Med."},{"key":"BFnrneph20167_CR87","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.transproceed.2009.08.072","volume":"41","author":"Y Wang","year":"2009","unstructured":"Wang, Y., Zhang, A., Ye, Z., Xie, H. & Zheng, S. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion. Transplant. Proc. 41, 4352\u20134356 (2009).","journal-title":"Transplant. Proc."},{"key":"BFnrneph20167_CR88","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00441-014-1956-z","volume":"358","author":"X Jiang","year":"2014","unstructured":"Jiang, X.  et al. CD4+CD25+ regulatory T cells are not required for mesenchymal stem cell function in fully MHC-mismatched mouse cardiac transplantation. Cell Tissue Res. 358, 503\u2013514 (2014).","journal-title":"Cell Tissue Res."},{"key":"BFnrneph20167_CR89","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","volume":"90","author":"W Ge","year":"2010","unstructured":"Ge, W.  et al. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation 90, 1312\u20131320 (2010).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR90","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/TP.0000000000000856","volume":"99","author":"Y He","year":"2015","unstructured":"He, Y.  et al. Indoleamine 2, 3-dioxgenase transfected mesenchymal stem cells induce kidney allograft tolerance by increasing the production and function of regulatory T cells. Transplantation 99, 1829\u20131838 (2015).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR91","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1089\/scd.2012.0096","volume":"21","author":"M Franquesa","year":"2012","unstructured":"Franquesa, M.  et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 21, 3125\u20133135 (2012).","journal-title":"Stem Cells Dev."},{"key":"BFnrneph20167_CR92","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1432-2277.2011.01328.x","volume":"24","author":"Y Hara","year":"2011","unstructured":"Hara, Y.  et al. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl. Int. 24, 1112\u20131123 (2011).","journal-title":"Transpl. Int."},{"key":"BFnrneph20167_CR93","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2012.00202","volume":"3","author":"M Seifert","year":"2012","unstructured":"Seifert, M., Stolk, M., Polenz, D. & Volk, H. D. Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection. Front. Immunol. 3, 202 (2012).","journal-title":"Front. Immunol."},{"key":"BFnrneph20167_CR94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trim.2013.08.004","volume":"29","author":"M Koch","year":"2013","unstructured":"Koch, M.  et al. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transpl. Immunol. 29, 43\u201350 (2013).","journal-title":"Transpl. Immunol."},{"key":"BFnrneph20167_CR95","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","volume":"12","author":"F Casiraghi","year":"2012","unstructured":"Casiraghi, F.  et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am. J. Transplant. 12, 2373\u20132383 (2012).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR96","first-page":"561098","volume":"2013","author":"LA Marquez-Curtis","year":"2013","unstructured":"Marquez-Curtis, L. A. & Janowska-Wieczorek, A. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1\/CXCR4 axis. Biomed. Res. Int. 2013, 561098 (2013).","journal-title":"Biomed. Res. Int."},{"key":"BFnrneph20167_CR97","doi-asserted-by":"crossref","first-page":"e82949","DOI":"10.1371\/journal.pone.0082949","volume":"8","author":"Z Cao","year":"2013","unstructured":"Cao, Z.  et al. Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model. PLoS ONE 8, e82949 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneph20167_CR98","doi-asserted-by":"crossref","first-page":"F1064","DOI":"10.1152\/ajprenal.00178.2013","volume":"305","author":"N Liu","year":"2013","unstructured":"Liu, N., Patzak, A. & Zhang, J. CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury. Am. J. Physiol. Renal Physiol. 305, F1064\u2013F1073 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph20167_CR99","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico, N.  et al. Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 6, 412\u2013422 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph20167_CR100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","volume":"26","author":"N Perico","year":"2013","unstructured":"Perico, N.  et al. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation. Transpl. Int. 26, 867\u2013878 (2013).","journal-title":"Transpl. Int."},{"key":"BFnrneph20167_CR101","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan, J.  et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307, 1169\u20131177 (2012).","journal-title":"JAMA"},{"key":"BFnrneph20167_CR102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders, M. E.  et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl. Med. 2, 107\u2013111 (2013).","journal-title":"Stem Cells Transl. Med."},{"key":"BFnrneph20167_CR103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nep.12338","volume":"20","author":"C Mudrabettu","year":"2015","unstructured":"Mudrabettu, C.  et al. Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study. Nephrology (Carlton) 20, 25\u201333 (2015).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph20167_CR104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","volume":"95","author":"Y Peng","year":"2013","unstructured":"Peng, Y.  et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation 95, 161\u2013168 (2013).","journal-title":"Transplantation"},{"key":"BFnrneph20167_CR105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2215\/CJN.01841105","volume":"1","author":"P Ruggenenti","year":"2006","unstructured":"Ruggenenti, P.  et al. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation. Clin. J. Am. Soc. Nephrol. 1, 546\u2013554 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph20167_CR106","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1600-6143.2011.03572.x","volume":"11","author":"AB Farris","year":"2011","unstructured":"Farris, A. B.  et al. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am. J. Transplant. 11, 1464\u20131477 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR107","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","volume":"8","author":"JA Bluestone","year":"2008","unstructured":"Bluestone, J. A.  et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am. J. Transplant. 8, 2086\u20132096 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR108","unstructured":"US National Library of Science. ClinicalTrials.gov\n                    [online]\n                    \n                  , (2015)."},{"key":"BFnrneph20167_CR109","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","volume":"353","author":"F Vincenti","year":"2005","unstructured":"Vincenti, F.  et al. Costimulation blockade with belatacept in renal transplantation. N. Engl. J. Med. 353, 770\u2013781 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph20167_CR110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.2012.6370","volume":"308","author":"LV Riella","year":"2012","unstructured":"Riella, L. V. & Chandraker, A. Stem cell therapy in kidney transplantation. JAMA 308, 130; author reply 130\u2013131 (2012).","journal-title":"JAMA"},{"key":"BFnrneph20167_CR111","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2012.67","volume":"91","author":"MD Griffin","year":"2013","unstructured":"Griffin, M. D.  et al. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol. Cell Biol. 91, 40\u201351 (2013).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrneph20167_CR112","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbmt.2006.12.447","volume":"13","author":"AT Badillo","year":"2007","unstructured":"Badillo, A. T., Beggs, K. J., Javazon, E. H., Tebbets, J. C. & Flake, A. W. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol. Blood Marrow Transplant. 13, 412\u2013422 (2007).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"BFnrneph20167_CR113","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3727\/000000006783981503","volume":"15","author":"KJ Beggs","year":"2006","unstructured":"Beggs, K. J.  et al. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant. 15, 711\u2013721 (2006).","journal-title":"Cell Transplant."},{"key":"BFnrneph20167_CR114","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.exphem.2010.06.011","volume":"38","author":"IA Isakova","year":"2010","unstructured":"Isakova, I. A., Dufour, J., Lanclos, C., Bruhn, J. & Phinney, D. G. Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs. Exp. Hematol. 38, 957\u2013967.e1 (2010).","journal-title":"Exp. Hematol."},{"key":"BFnrneph20167_CR115","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00277-012-1438-x","volume":"91","author":"M Zaim","year":"2012","unstructured":"Zaim, M., Karaman, S., Cetin, G. & Isik, S. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann. Hematol. 91, 1175\u20131186 (2012).","journal-title":"Ann. Hematol."},{"key":"BFnrneph20167_CR116","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/exd.12459","volume":"23","author":"K Nemeth","year":"2014","unstructured":"Nemeth, K. Mesenchymal stem cell therapy for immune-modulation: the donor, the recipient, and the drugs in-between. Exp. Dermatol. 23, 625\u2013628 (2014).","journal-title":"Exp. Dermatol."},{"key":"BFnrneph20167_CR117","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1741-7015-11-146","volume":"11","author":"G Siegel","year":"2013","unstructured":"Siegel, G.  et al. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. 11, 146 (2013).","journal-title":"BMC Med."},{"key":"BFnrneph20167_CR118","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/ajt.12358","volume":"13","author":"G Remuzzi","year":"2013","unstructured":"Remuzzi, G. & Bromberg, J. S. Mesenchymal stromal cells: what's in the name? (and for what?). Am. J. Transplant. 13, 1625 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph20167_CR119","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","volume":"18","author":"L von Bahr","year":"2012","unstructured":"von Bahr, L.  et al. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol. Blood Marrow Transplant. 18, 557\u2013564 (2012).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"BFnrneph20167_CR120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0609.2012.01824.x","volume":"89","author":"U Forslow","year":"2012","unstructured":"Forslow, U.  et al. Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation. Eur. J. Haematol. 89, 220\u2013227 (2012).","journal-title":"Eur. J. Haematol."},{"key":"BFnrneph20167_CR121","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1213779","volume":"368","author":"T Kawai","year":"2013","unstructured":"Kawai, T., Sachs, D. H., Sykes, M. & Cosimi, A. B. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 368, 1850\u20131852 (2013).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2016.7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2016.7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2016.7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:49:12Z","timestamp":1684471752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2016.7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFnrneph20167"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2016.7","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]},"assertion":[{"value":"8 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}